Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Lupus Nephritis Global Clinical Trials Review, H1

Lupus Nephritis Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Lupus Nephritis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Lupus Nephritis Global Clinical Trials Review, H1, 2015" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Lupus Nephritis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Lupus Nephritis 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Lupus Nephritis 33

Mar 30, 2015: Aurinia Highlights Initiation of Its Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

F. Hoffmann-La Roche Ltd. 34

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34

Novartis AG 35

Clinical Trial Overview of Novartis AG 35

Astellas Pharma Inc. 36

Clinical Trial Overview of Astellas Pharma Inc. 36

Biogen, Inc. 37

Clinical Trial Overview of Biogen, Inc. 37

Johnson & Johnson 38

Clinical Trial Overview of Johnson & Johnson 38

Immune Tolerance Network 39

Clinical Trial Overview of Immune Tolerance Network 39

E. Merck KG 40

Clinical Trial Overview of E. Merck KG 40

Anthera Pharmaceuticals Inc. 41

Clinical Trial Overview of Anthera Pharmaceuticals Inc. 41

Bristol-Myers Squibb Company 42

Clinical Trial Overview of Bristol-Myers Squibb Company 42

Aurinia Pharmaceuticals Inc. 43

Clinical Trial Overview of Aurinia Pharmaceuticals Inc. 43

Clinical Trial Overview of Top Institutes / Government 44

Nanjing University 44

Clinical Trial Overview of Nanjing University 44

Chinese University of Hong Kong 45

Clinical Trial Overview of Chinese University of Hong Kong 45

National Institute of Arthritis and Musculoskeletal and Skin Diseases 46

Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 46

The National Institute of Allergy and Infectious Diseases 47

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 47

All India Institute of Medical Sciences 48

Clinical Trial Overview of All India Institute of Medical Sciences 48

Chulalongkorn University 49

Clinical Trial Overview of Chulalongkorn University 49

Sun Yat-sen University 50

Clinical Trial Overview of Sun Yat-sen University 50

Tuen Mun Hospital 51

Clinical Trial Overview of Tuen Mun Hospital 51

Assistance Publique Hopitaux De Marseille 52

Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 52

Cambridge University Hospitals NHS Foundation Trust 53

Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 53

Five Key Clinical Profiles 54

Appendix 75

Abbreviations 75

Definitions 75

Research Methodology 76

Secondary Research 76

About GlobalData 77

Contact Us 77

Disclaimer 77

Source 78

List of Figures

Lupus Nephritis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2015* 15

Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2015* 18

Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 76

List of Tables

Lupus Nephritis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2015* 15

Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2015* 18

Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Lupus Nephritis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Lupus Nephritis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Lupus Nephritis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 34

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 35

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 36

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen, Inc., 2015* 37

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 38

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immune Tolerance Network, 2015* 39

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 40

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals Inc., 2015* 41

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 42

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurinia Pharmaceuticals Inc., 2015* 43

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing University, 2015* 44

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 45

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015* 46

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 47

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 48

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chulalongkorn University, 2015* 49

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 50

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuen Mun Hospital, 2015* 51

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2015* 52

Lupus Nephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2015* 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

F. Hoffmann-La Roche Ltd.

Novartis AG

Astellas Pharma Inc.

Biogen, Inc.

Johnson & Johnson

Immune Tolerance Network

E. Merck KG

Anthera Pharmaceuticals Inc.

Bristol-Myers Squibb Company

Aurinia Pharmaceuticals Inc.

Lupus Nephritis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Lupus Nephritis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com